802 related articles for article (PubMed ID: 31763115)
21. [Correction of gut dysbiosis as a promising direction in the prevention of neuroinflammation and cognitive impairment].
Shikh EV; Nikolaeva NB; Molchanova NB; Elizarova EV
Vopr Pitan; 2023; 92(6):107-119. PubMed ID: 38198424
[TBL] [Abstract][Full Text] [Related]
22. Probiotics for Parkinson's Disease.
Gazerani P
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450864
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease.
Singh Y; Trautwein C; Romani J; Salker MS; Neckel PH; Fraccaroli I; Abeditashi M; Woerner N; Admard J; Dhariwal A; Dueholm MKD; Schäfer KH; Lang F; Otzen DE; Lashuel HA; Riess O; Casadei N
Mol Neurodegener; 2023 Jul; 18(1):44. PubMed ID: 37403161
[TBL] [Abstract][Full Text] [Related]
24. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
[TBL] [Abstract][Full Text] [Related]
26. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
27. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
28. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
29. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
[TBL] [Abstract][Full Text] [Related]
30. Gut-directed therapy in Parkinson's disease.
Benvenuti L; Di Salvo C; Bellini G; Seguella L; Rettura F; Esposito G; Antonioli L; Ceravolo R; Bernardini N; Pellegrini C; Fornai M
Front Pharmacol; 2024; 15():1407925. PubMed ID: 38974034
[TBL] [Abstract][Full Text] [Related]
31. Role of the Gut-Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson's Disease.
Thangaleela S; Sivamaruthi BS; Kesika P; Bharathi M; Chaiyasut C
Microorganisms; 2022 Jul; 10(8):. PubMed ID: 36013962
[TBL] [Abstract][Full Text] [Related]
32. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation.
Dutta SK; Verma S; Jain V; Surapaneni BK; Vinayek R; Phillips L; Nair PP
J Neurogastroenterol Motil; 2019 Jul; 25(3):363-376. PubMed ID: 31327219
[TBL] [Abstract][Full Text] [Related]
33. The Gut and Parkinson's Disease-A Bidirectional Pathway.
Santos SF; de Oliveira HL; Yamada ES; Neves BC; Pereira A
Front Neurol; 2019; 10():574. PubMed ID: 31214110
[TBL] [Abstract][Full Text] [Related]
34. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
35. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
36. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
[TBL] [Abstract][Full Text] [Related]
37. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
Chiang HL; Lin CH
J Mov Disord; 2019 May; 12(2):67-83. PubMed ID: 31158941
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer's and Parkinson's Diseases.
Ayten Ş; Bilici S
Curr Nutr Rep; 2024 Jun; 13(2):82-96. PubMed ID: 38652236
[TBL] [Abstract][Full Text] [Related]
40. Disease mechanisms as subtypes: Microbiome.
Bonvegna S; Cilia R
Handb Clin Neurol; 2023; 193():107-131. PubMed ID: 36803806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
